
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MAGI-1 CRISPR/Cas9 KO Plasmid (h) | sc-402283 | 20 µg | $397.00 |
MAGI1 encodes MAGI-1, a membrane-associated guanylate kinase (MAGUK) scaffold protein enriched at tight junctions and other cell–cell contact sites where it organizes multiprotein signaling complexes. By binding junctional components and signaling effectors through PDZ and WW domains, MAGI-1 helps coordinate epithelial polarity, adherens/tight junction stability, and spatial regulation of pathways linked to cytoskeletal remodeling and signal transduction. Altered MAGI1 expression or junctional localization has been associated with disruption of barrier function and aberrant cell migration programs, processes frequently studied in cancer biology and inflammatory tissue remodeling. MAGI-1 is also used as a node to interrogate cross-talk between junctional architecture and growth factor–responsive signaling networks.
MAGI-1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the MAGI1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the MAGI1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the MAGI1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MAGI-1 protein expression.
This CRISPR knockout system enables efficient generation of MAGI1-deficient cell models for investigation of MAGI-1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.